“…The results presented above demonstrate the ability of data from a phybrata sensor worn on the mastoid to confirm clinical diagnosis of concussion, provide independent measures that confirm the presence of accompanying neurological and vestibular impairments, and quantify the progression of multi-system physiological impairments and sensory reweighting following concussion. ROC results have been previously reported for a variety of concussion diagnostics tools and biomarkers, including symptoms inventories, 146,147 neurocognitive testing, [148][149][150][151][152][153][154] analyses of head impact kinematics, [155][156][157][158] postural stability assessments, 39,159,160 gait analysis, 161 eye movement tracking, [162][163][164][165][166] vestibular and oculomotor screening, 167,168 visually evoked potentials, 169 electrovestibulography, 45 robotic assessment of neuromotor performance, 170 blood-based biomarkers, [171][172][173][174] salivary biomarkers, 175 EEG, 176 and MRI assessments of alterations in cerebral blood flow. 177 Many components of traditional neurocognitive testing have been shown to have limited predictive value, 151 and the use of reduced variable subsets (including balance and eye tracking) has recently been recommended.…”